OFI Invest Asset Management Takes $4.11 Million Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

OFI Invest Asset Management bought a new position in Intuitive Surgical, Inc. (NASDAQ:ISRG) during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm bought 8,150 shares of the medical equipment provider’s stock, valued at approximately $4,108,000.

Other large investors have also added to or reduced their stakes in the company. Dorsey & Whitney Trust CO LLC grew its holdings in shares of Intuitive Surgical by 4.2% in the fourth quarter. Dorsey & Whitney Trust CO LLC now owns 4,931 shares of the medical equipment provider’s stock worth $2,574,000 after acquiring an additional 201 shares during the period. Fairfield Financial Advisors LTD grew its stake in shares of Intuitive Surgical by 50.2% during the 4th quarter. Fairfield Financial Advisors LTD now owns 4,921 shares of the medical equipment provider’s stock valued at $2,569,000 after purchasing an additional 1,645 shares during the period. Naviter Wealth LLC increased its position in shares of Intuitive Surgical by 616.1% during the 4th quarter. Naviter Wealth LLC now owns 3,595 shares of the medical equipment provider’s stock valued at $1,876,000 after purchasing an additional 3,093 shares during the last quarter. Lifeworks Advisors LLC bought a new position in shares of Intuitive Surgical in the 4th quarter worth approximately $222,000. Finally, Larson Financial Group LLC boosted its holdings in shares of Intuitive Surgical by 379.7% in the fourth quarter. Larson Financial Group LLC now owns 4,097 shares of the medical equipment provider’s stock worth $2,139,000 after buying an additional 3,243 shares during the last quarter. Institutional investors own 83.64% of the company’s stock.

Insider Transactions at Intuitive Surgical

In related news, SVP Mark Brosius sold 489 shares of Intuitive Surgical stock in a transaction dated Friday, March 7th. The stock was sold at an average price of $533.18, for a total value of $260,725.02. Following the completion of the transaction, the senior vice president now owns 2,091 shares in the company, valued at approximately $1,114,879.38. This trade represents a 18.95 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, Director Amal M. Johnson sold 4,635 shares of the company’s stock in a transaction that occurred on Tuesday, January 28th. The shares were sold at an average price of $566.60, for a total value of $2,626,191.00. Following the sale, the director now owns 12,275 shares in the company, valued at approximately $6,955,015. This trade represents a 27.41 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 13,579 shares of company stock worth $7,756,844 in the last three months. Insiders own 0.90% of the company’s stock.

Wall Street Analyst Weigh In

Several research firms have weighed in on ISRG. Barclays increased their price target on shares of Intuitive Surgical from $610.00 to $674.00 in a research report on Monday, January 27th. BTIG Research boosted their price target on Intuitive Surgical from $535.00 to $561.00 and gave the company a “buy” rating in a report on Tuesday, November 26th. Stifel Nicolaus lifted their price objective on Intuitive Surgical from $525.00 to $610.00 and gave the company a “buy” rating in a research report on Thursday, December 5th. Leerink Partners increased their target price on shares of Intuitive Surgical from $490.00 to $548.00 in a report on Monday, January 27th. Finally, Morgan Stanley raised shares of Intuitive Surgical from an “equal weight” rating to an “overweight” rating and lifted their price target for the company from $522.00 to $650.00 in a report on Monday, December 2nd. One research analyst has rated the stock with a sell rating, four have issued a hold rating and sixteen have given a buy rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $613.10.

Intuitive Surgical Stock Performance

Shares of ISRG opened at $518.26 on Friday. The stock has a market capitalization of $184.59 billion, a PE ratio of 80.85, a P/E/G ratio of 5.85 and a beta of 1.43. The company’s fifty day moving average is $571.36 and its 200 day moving average is $531.53. Intuitive Surgical, Inc. has a fifty-two week low of $364.17 and a fifty-two week high of $616.00.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.